Anti-PEX14 antibody - Carboxyterminal end (ab95102)

Overview

  • Product nameAnti-PEX14 antibody - Carboxyterminal end
    See all PEX14 primary antibodies
  • Description
    Rabbit polyclonal to PEX14 - Carboxyterminal end
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    KLH conjugated synthetic peptide selected from the C-terminal region of Human PEX14 (NP_004556.1).

  • Positive control
    • HL-60 cell line lysate

Properties

Applications

Our Abpromise guarantee covers the use of ab95102 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/100 - 1/500. Predicted molecular weight: 37 kDa. (Isoform 2)

Target

  • FunctionComponent of the peroxisomal translocation machinery with PEX13 and PEX17. Interacts with both the PTS1 and PTS2 receptors. Binds directly to PEX17.
  • Involvement in diseaseDefects in PEX14 are the cause of peroxisome biogenesis disorder complementation group K (PBD-CGK) [MIM:601791]. PBD-CGK is a peroxisomal disorder arising from a failure of protein import into the peroxisomal membrane or matrix. The peroxisome biogenesis disorders (PBD group) are genetically heterogeneous with at least 14 distinct genetic groups as concluded from complementation studies. Include disorders are: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). ZWS, NALD and IRD are distinct from RCDP and constitute a clinical continuum of overlapping phenotypes known as the Zellweger spectrum (PBD-ZSS).
    Defects in PEX14 are a cause of Zellweger syndrome (ZWS) [MIM:214100]. ZWS is a fatal peroxisome biogenesis disorder characterized by dysmorphic facial features, hepatomegaly, ocular abnormalities, renal cysts, hearing impairment, profound psychomotor retardation, severe hypotonia and neonatal seizures. Death occurs within the first year of life.
  • Sequence similaritiesBelongs to the peroxin-14 family.
  • Cellular localizationPeroxisome membrane.
  • Information by UniProt
  • Database links
  • Alternative names
    • dJ734G22.2 antibody
    • NAPP2 antibody
    • NF E2 associated polypeptide 2 antibody
    • Peroxin 14 antibody
    • Peroxin-14 antibody
    • Peroxisomal biogenesis factor 14 antibody
    • Peroxisomal membrane anchor protein PEX14 antibody
    • Peroxisomal membrane anchor protein Pex14p antibody
    • Peroxisomal membrane protein PEX14 antibody
    • pex14 antibody
    • PEX14_HUMAN antibody
    • Pex14p antibody
    • PTS1 receptor docking protein antibody
    • PTS1 receptor-docking protein antibody
    see all

Anti-PEX14 antibody - Carboxyterminal end images

  • Anti-PEX14 antibody - Carboxyterminal end (ab95102) at 1/100 dilution + HL-60 cell line lysate at 35 µg

    Predicted band size : 37 kDa

References for Anti-PEX14 antibody - Carboxyterminal end (ab95102)

ab95102 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab95102.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"